Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines

Oncogene

Volumn 16, Issue 24, 1998, Pages 3143-3149

  White, A ^a   Lamb, P W ^a   Barrett, J C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

KAI1 (CD82); Metastasis suppressor gene; Prostate cancer; Transmembrane four superfamily

Indexed keywords

CD81 ANTIGEN; CD82 ANTIGEN; CD9 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11P; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOCYTE; METASTASIS INHIBITION; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 0032543716     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201852     Document Type: Article

References (27)

1. Adachi M, Taki T, Ieki Y, Huang C, Higashiyama M and Miyake M. (1996). Cancer Res., 56, 1751-1755.
2. Angelisova P, Hilgert I and Horejsi V. (1994). Immunogenetics, 39, 249-256.
3. Atkinson B, Ernst CS, Ghrist BFD, Ross AH, Clark WH, Herlyn M, Herlyn D, Maul G, Steplewski Z and Koprowski H. (1985). Hybridoma, 4, 243-255.
4. Berditchevski F, Zutter MM and Hemler ME. (1996). Mol. Biol. Cell, 7, 193-207.
5. Dear TN and Kefford RF. (1990). Mol. Aspects Med., 11, 243-324.
6. Dennis JW. (1991). Semin. Cancer Biol., 2, 411-420.
7. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC. (1995). Science, 268, 884-886.
8. Dong JT, Suzuki H, Pin SS, Bova S, Schalken JA, Isaacs WB, Barrett JC and Isaacs JT. (1996). Cancer Res., 56, 4387-4390.
9. Engel P and Tedder TF. (1994). Leuk. Lymphoma. 13, 61-64.
10. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y and Yoshie O. (1992). J. Virol., 66, 1394-1401.
11. Fusenig NE, Breitkreutz D and Boukamp P. (1991). Human Cancer in Primary Culture. Masters JRW (ed.), Kluwer Academic Publishers: Netherlands, pp. 55-80.
12. Gaugitsch HW, Hofer E, Huber NE, Schnabl E and Baumruker T. (1991). Eur. J. Immunol., 21, 377-383.
13. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Kore M and Buchler MW. (1996). Cancer Res., 56, 4876-4880.
14. Ikeyama S, Koyama M, Yamaoko M, Sasada R and Miyake M. (1993). J. Exp. Med., 177, 1231-1237.
15. Imai T and Yoshie O. (1993). J. Immunol., 151, 6470-6481.
16. Kakizoe T, Fair WR, Smith PH, Algoba F, Ferrari P, Grossman HB, Zirkali Z, Tsukamoto T and Tachibana M. (1995). Int. J. Urol., 2 suppl 2, 58-63.
17. Kohn EC. (1993). Anticancer Res., 13, 2553-2560.
18. Lagaudriere-Gesbert C, Lebel-Binay S, Wiertz E, Ploegh HL, Fradelizi D, and Conjeaud H. (1997). J. Immunol., 158, 2790-2797.
19. Lebel-Binay S, Gil ML, Lagaudriere C, Miloux B, Marchiol-Fournigault C, Guillet-Mary A, Lopez M, Fradelizi D, and Conjeaud H. (1994). Cell. Immunol., 154, 468-483.
20. Miyake M, Koyama M, Seno M and Ikeyama S. (1991). J. Exp. Med., 174, 1347-1354.
21. Miyake M, Nakano K, Ieki Y, Adachi M, Huang C, Itoi S, Koh T and Taki T. (1995). Cancer Res., 55, 4127-4131.
22. Nojima Y, Hirose T, Tachibana K, Tanaka T, Shi L, Doshen J, Freeman GJ, Schlossman SF, and Morimoto C. (1993). Cell. Immunol., 152, 249-260.
23. Oren R, Takahashi S, Doss C, Levy R and Levy S. (1990). Mol. Cell. Biol., 10, 4007-4015.
24. Rubinstein E, Naour FL, Lagaudriere-Gesbert C, Billard M, Conjeaud H, and Boucheix C. (1996). Eur. J. Immunol., 26, 2657-2665.
25. Sharkey FE and Fogh J. (1979). Int. J. Cancer, 24, 733-738.
26. Takahashi S, Doss C, Levy S, and Levy R. (1990). J. Immunol., 145, 2207-2213.
27. Ueda T, Ichikawa T, Tamaru J, Mikata A, Akakura K, Akimoto S, Imai T, Yoshie O, Shiraishi T, Yatani R, Ito H and Shimazaki J. (1996). Am. J. Pathol., 149, 1435-1440.